BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32048593)

  • 1. Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.
    Gutzmer R; Wiegand S; Kölbl O; Wermker K; Heppt M; Berking C
    Dtsch Arztebl Int; 2019 Sep; 116(37):616-626. PubMed ID: 32048593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for actinic keratoses.
    Gupta AK; Paquet M; Villanueva E; Brintnell W
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD004415. PubMed ID: 23235610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review.
    Aggarwal I; Puyana C; Chandan N; Jetter N; Tsoukas M
    Am J Clin Dermatol; 2024 May; 25(3):391-405. PubMed ID: 38351246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
    Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
    JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
    Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of Topical Calcipotriol Plus 5-Fluorouracil in the Treatment of Actinic Keratosis: A Systematic Review.
    Mohney L; Singh R; Grada A; Feldman S
    J Drugs Dermatol; 2022 Jan; 21(1):60-65. PubMed ID: 35005863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy of actinic keratosis: an update.
    Berman B; Amini S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1847-71. PubMed ID: 22888917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary management of actinic keratosis.
    Navarrete-Dechent C; Marghoob AA; Marchetti MA
    J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The paradigm shift in treating actinic keratosis: a comprehensive strategy.
    Stockfleth E
    J Drugs Dermatol; 2012 Dec; 11(12):1462-7. PubMed ID: 23377517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian expert consensus for the management of actinic keratosis in immunocompetent patients.
    Peris K; Calzavara-Pinton PG; Neri L; Girolomoni G; Malara G; Parodi A; Piaserico S; Rossi R; Pellacani G
    J Eur Acad Dermatol Venereol; 2016 Jul; 30(7):1077-84. PubMed ID: 27060910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma - short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality-of-care indicators.
    Heppt MV; Leiter U; Steeb T; Amaral T; Bauer A; Becker JC; Breitbart E; Breuninger H; Diepgen T; Dirschka T; Eigentler T; Flaig M; Follmann M; Fritz K; Greinert R; Gutzmer R; Hillen U; Ihrler S; John SM; Kölbl O; Kraywinkel K; Löser C; Nashan D; Noor S; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Welzel J; Wermker K; Berking C; Garbe C
    J Dtsch Dermatol Ges; 2020 Mar; 18(3):275-294. PubMed ID: 32130773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of actinic keratosis: a practical report and treatment algorithm from AKTeam™ expert clinicians.
    Dréno B; Amici JM; Basset-Seguin N; Cribier B; Claudel JP; Richard MA;
    J Eur Acad Dermatol Venereol; 2014 Sep; 28(9):1141-9. PubMed ID: 24612407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) - short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow-up, prevention and occupational disease.
    Leiter U; Heppt MV; Steeb T; Amaral T; Bauer A; Becker JC; Breitbart E; Breuninger H; Diepgen T; Dirschka T; Eigentler T; Flaig M; Follmann M; Fritz K; Greinert R; Gutzmer R; Hillen U; Ihrler S; John SM; Kölbl O; Kraywinkel K; Löser C; Nashan D; Noor S; Nothacker M; Pfannenberg C; Salavastru C; Schmitz L; Stockfleth E; Szeimies RM; Ulrich C; Welzel J; Wermker K; Garbe C; Berking C
    J Dtsch Dermatol Ges; 2020 Apr; 18(4):400-413. PubMed ID: 32247292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
    Schmitt AR; Bordeaux JS
    Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Actinic keratosis and squamous cell carcinoma of the elderly].
    Colboc H; Meaume S
    Rev Prat; 2017 Dec; 67(10):1084-1088. PubMed ID: 30512606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ingenol Mebutate Is Associated With Increased Reporting Odds for Squamous Cell Carcinoma in Actinic Keratosis Patients, a Pharmacovigilance Study of the FDA Adverse Event Reporting System (FAERS).
    Jedlowski PM
    J Cutan Med Surg; 2023; 27(1):39-43. PubMed ID: 36495205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current therapies for actinic keratosis.
    Dianzani C; Conforti C; Giuffrida R; Corneli P; di Meo N; Farinazzo E; Moret A; Magaton Rizzi G; Zalaudek I
    Int J Dermatol; 2020 Jun; 59(6):677-684. PubMed ID: 32012240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
    Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
    Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
    Cheng B; Veerabagu S; Miller CJ; Sobanko JF; Shin TM; Higgins HW; Giordano CN; Etzkorn JR
    J Am Acad Dermatol; 2022 Sep; 87(3):592-596. PubMed ID: 35661760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical management of actinic keratosis and field cancerisation.
    Stockfleth E
    G Ital Dermatol Venereol; 2009 Aug; 144(4):459-62. PubMed ID: 19755950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.